Analyst Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) and keeping the price target at ...

Coya Therapeutics (COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for the treatment of inflammatory ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

AUSTIN - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a micro-cap biotech company with a market capitalization of $18.78 ...

A year after going public, ArriVent BioPharma is continuing to bolster its antibody-drug conjugate pipeline via licensing ...

Kate Therapeutics' pipeline is still in the preclinical stage of development but includes candidates for DMD, facioscapulohumeral dystrophy (FSHD), and myotonic dystrophy type 1 (DM1), as well as ...

It should have plenty of fuel to continue growing its payout in the future. Pipeline companies tend to be excellent investments for those seeking passive income. They generate very stable revenue ...

After hours: January 22 at 5:04:00 PM EST Loading Chart for HRTX ...

Dyne Therapeutics Inc. 2.97% $1.44B ...

Matalan PJs for the whole family not forgetting the Facebook on sale, Dune Radio Trending First details of this year s Matalan Alder on sale, Pet TogetherForAlderHey Outfit Small Large on sale, ...